We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Two congressmen introduced right-to-try legislation in the House this week, which could find broad support from Congress and the White House. Read More
More than 160 biotech executives, investors and researchers have signed on to a letter opposing President Trump’s executive order restricting immigration from seven Middle Eastern and African countries. Read More
Teva Pharmaceuticals has been named in a patent infringement lawsuit as it attempts to develop a generic version of Belbuca, a long-acting opioid painkiller sponsored by BioDelivery Sciences International and Arius Two. Read More
In a setback for generics makers, AstraZeneca prevailed in a patent-infringement lawsuit when a federal judge validated the company’s patent for the diabetes drug Onglyza. Read More
Aspen Pharma and Deco Pharma, the company’s distributor, face disciplinary proceedings from Spain’s antitrust authority for allegedly limiting the distribution and hiking the prices of drugs. Read More
A lawsuit filed by the state of California alleges several drug manufacturers made a “pay-for-delay” deal to keep generic competition off the market. Read More
Former FDA deputy commissioner Scott Gottlieb emerged as the favorite to serve as the next leader of the FDA in a survey of 53 pharmaceutical companies. Read More